PIRAMALFIN:NSEPiramal Finance Limited Analysis
Data as of 2026-03-15 - not real-time
₹1,746.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Piramal Finance is trading at INR 1,746.9, which sits slightly below its 20‑day (≈1,771.8) and 50‑day (≈1,774.8) simple moving averages, indicating short‑term pressure. The 200‑day SMA (≈1,680.3) remains beneath the current price, suggesting the longer‑term trend is still intact. The RSI of 46.6 points to a neutral momentum environment, while the MACD histogram is negative and the signal line is labeled “bearish,” hinting at potential downside momentum. Volume is on an increasing trend, providing liquidity for any near‑term price moves. The 30‑day volatility of roughly 20 % and a beta of 0.41 reflect moderate price swings and low correlation to the broader market. The market sentiment index reads 72.9, classifying the environment as “Greed,” which may fuel speculative buying despite the mixed technical signals.
On the fundamentals side, revenue has surged 55.9 % year‑over‑year, and operating margins sit at 17.4 % with a profit margin of 13.4 %. However, the current trailing PE of 64.1 is far above the industry average of 16.4, flagging a significant valuation premium. The forward PE of 18.9, together with a target median price of INR 1,960, implies a modest upside of about 6‑7 % and a potential compression of valuation multiples. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 261 % and total debt dwarfing cash reserves, raising concerns about financial resilience. The company does not pay a dividend, and its payout ratio is zero, indicating that dividend sustainability is not applicable. Analyst consensus (7 analysts) leans toward a “Buy” recommendation, driven by strong growth prospects but tempered by high leverage and an elevated current valuation.
On the fundamentals side, revenue has surged 55.9 % year‑over‑year, and operating margins sit at 17.4 % with a profit margin of 13.4 %. However, the current trailing PE of 64.1 is far above the industry average of 16.4, flagging a significant valuation premium. The forward PE of 18.9, together with a target median price of INR 1,960, implies a modest upside of about 6‑7 % and a potential compression of valuation multiples. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 261 % and total debt dwarfing cash reserves, raising concerns about financial resilience. The company does not pay a dividend, and its payout ratio is zero, indicating that dividend sustainability is not applicable. Analyst consensus (7 analysts) leans toward a “Buy” recommendation, driven by strong growth prospects but tempered by high leverage and an elevated current valuation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price testing support at 1,675.5
- bearish MACD divergence
- increasing volume suggests potential bounce
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong revenue growth of 55.9%
- forward PE of 18.9 indicating valuation compression
- analyst target price upside of ~6‑7%
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- high debt‑to‑equity ratio poses balance‑sheet risk
- sustained operating margins and cash generation potential
- ongoing demand for housing finance in India
Key Metrics & Analysis
Financial Health
Revenue Growth55.90%
Profit Margin13.38%
P/E Ratio64.1
Debt/Equity261.15
P/B Ratio1.4
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI46.6
Support₹1,675.50
Resistance₹1,828.50
MA 20₹1,771.79
MA 50₹1,774.81
MA 200₹1,680.33
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price₹1,865.71
Upside/Downside6.80%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.41
Volatility20.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.